Jubilant Ingrevia Ltd. (IN:JUBLINGREA)
:JUBLINGREA
JUBLINGREA Stock Chart & Stats
₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)
Day’s Range― - ―
52-Week Range₹535.30 - ₹851.85
Previous CloseN/A
Volume517.05K
Average Volume (3M)13.09K
Market Cap
₹88.76B
Enterprise Value₹95.69B
Total Cash (Recent Filing)₹469.10M
Total Debt (Recent Filing)₹8.06B
Price to Earnings (P/E)59.2
Beta0.92
Next Earnings
May 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.74%
Share Statistics
EPS (TTM)3.00
Shares Outstanding159,281,140
10 Day Avg. Volume10,350
30 Day Avg. Volume13,091
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.53
Price to Sales (P/S)2.47
P/FCF Ratio72.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.29
Revenue Forecast (FY)₹44.39B
Bulls Say, Bears Say
Bulls Say
Integrated Manufacturing & Diversified End-marketsJubilant Ingrevia’s combined chemical-synthesis and fermentation capabilities create durable vertical integration across pharmaceuticals, nutrition, agrochemicals and industrials. This integration supports cost control, product breadth, reliable supply and sticky B2B contracts, underpinning repeat revenue and margin resilience over several quarters.
Stable Profit Margins And Consistent ProfitabilityThe company’s stable EBIT/EBITDA margins and improving gross and net margins reflect operational efficiency and pricing power in specialty ingredients. Durable margin stability indicates ability to absorb input cost swings and sustain profitability across business cycles, supporting long-term cash generation and reinvestment capacity.
Improving Cash Generation And Positive FCF TrendRecent robust operating cash flow and a return to positive free cash flow strengthen the company’s financial flexibility. Improved cash generation enables self-funding of maintenance and growth capex, lowers reliance on external financing, and enhances the ability to invest in higher-margin bio-based products and customer services over the medium term.
Bears Say
Revenue Volatility And 2024 DipA revenue dip in 2024, even with a 2025 recovery, highlights exposure to cyclical demand and end-market swings (pharma, agrochemicals, nutrition). Persistent volatility can impair capacity utilization and predictability of cash flows, complicating investment planning and potentially pressuring margins during weaker periods.
Rising Total Liabilities / Moderate LeverageWhile equity remains solid, the trend of rising total liabilities increases financial risk if growth stalls. Higher leverage can raise interest costs and reduce strategic flexibility, making the company more sensitive to revenue shocks and potentially limiting its ability to pursue acquisitions or sustained capex without external funding.
Prior Periods Of Negative Free Cash FlowHistoric episodes of negative free cash flow indicate that past capex or working-capital demands have outpaced operating cash generation. If such patterns recur, the firm may need external financing, which could raise costs or dilute shareholders and constrain long-term investment in higher-value bio and specialty product lines.
Jubilant Ingrevia Ltd. News
JUBLINGREA FAQ
What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹851.85 in the past 12 months.
What is Jubilant Ingrevia Ltd.’s market cap?
Jubilant Ingrevia Ltd.’s market cap is ₹88.76B.
When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
Jubilant Ingrevia Ltd.’s upcoming earnings report date is May 19, 2026 which is in 51 days.
How were Jubilant Ingrevia Ltd.’s earnings last quarter?
Jubilant Ingrevia Ltd. released its earnings results on Feb 04, 2026. The company reported ₹3 earnings per share for the quarter, missing the consensus estimate of ₹3.5 by -₹0.5.
Is Jubilant Ingrevia Ltd. overvalued?
According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued.
Does Jubilant Ingrevia Ltd. pay dividends?
Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.74%. See more information on Jubilant Ingrevia Ltd. dividends here
What is Jubilant Ingrevia Ltd.’s EPS estimate?
Jubilant Ingrevia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jubilant Ingrevia Ltd. have?
Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
Jubilant Ingrevia Ltd. reported an EPS of ₹3 in its last earnings report, missing expectations of ₹3.5. Following the earnings report the stock price went down -1.778%.
Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
Currently, no hedge funds are holding shares in IN:JUBLINGREA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
Technical Analysis
Alkyl Amines Chemicals Limited
―
―
Anupam Rasayan India Ltd.
―
Privi Speciality Chemicals Limited
―
Sudarshan Chemical Industries Limited
―